The complex CTLA-4/B7 blocks the anti-cancer activity of T1 and T8 cells [74], and at the same time it also increases the proliferation of Tr [75]; we assume that this increase in Tr is caused by a change from T1 to Tr phenotype, as in the case of PD-1/PD-L1. The gene discussed is CD274; the disease is cancer.